ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

Neuropathic pain is a chronic and debilitating condition that impacts around 10% of the population in both the United States and Europe. Despite advances in understanding the mechanisms of neuropathic ...

Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...

There are a great many things that men and women experience differently. A newly published study finds that chronic pain is one of them. It turns out that there are important distinctions in how ...

Injectable biologics may provide superior analgesia, functionality, and QOL vs conventional approaches to chronic pain, ...

Long-term, low-dose antiviral treatment reduces the risk ... were found to have a shorter duration of pain at 18 months and needed significantly less neuropathic pain medication.

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...

The researchers conclude that by tailoring pain treatment to an individual’s sex, it may be possible to improve patient outcomes and reduce the reliance on and misuse of opioids. "There are clear ...

The data published in The Lancet is being heralded as a big breakthrough in the treatment of cervical cancer and uses readily available chemotherapy drugs, given to patients before they receive ...